|
Re: Third Eye Loan
|
5
|
Resverlogix Corp.
|
Dec 28, 2018 11:23AM
|
|
Re: Third Eye Loan
|
5
|
Resverlogix Corp.
|
Dec 28, 2018 12:28PM
|
|
Re: Adjudication
|
2
|
Resverlogix Corp.
|
Dec 28, 2018 08:24PM
|
|
Happy New Year
|
6
|
Resverlogix Corp.
|
Jan 01, 2019 03:51AM
|
|
Happy New Year
|
5
|
Zenith Epigenetics
|
Jan 01, 2019 03:53AM
|
|
Re: Just for fun....
|
3
|
Resverlogix Corp.
|
Jan 03, 2019 12:46PM
|
|
Re: Important article published yesterday (January 4), RVX208 relevant
|
5
|
Resverlogix Corp.
|
Jan 05, 2019 12:17PM
|
|
Re: Revamped website
|
5
|
Resverlogix Corp.
|
Jan 06, 2019 09:43PM
|
|
Re: CNBC at the JPM Bio Tech Conference
|
2
|
Resverlogix Corp.
|
Jan 07, 2019 10:18AM
|
|
Re: Pfizer collaboration
|
4
|
Zenith Epigenetics
|
Jan 07, 2019 10:26AM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
5
|
Resverlogix Corp.
|
Jan 08, 2019 12:32PM
|
|
Re: ZE Slides Up
|
5
|
Zenith Epigenetics
|
Jan 08, 2019 04:36PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
4
|
Resverlogix Corp.
|
Jan 09, 2019 02:17PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 03:27PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
3
|
Resverlogix Corp.
|
Jan 09, 2019 04:19PM
|
|
Re: How long would the last enrolled patient have to be in the trail before their stats would be included.
|
3
|
Resverlogix Corp.
|
Jan 10, 2019 03:25AM
|
|
Re: Deadlines missed? Results Late? Not really.
|
4
|
Resverlogix Corp.
|
Jan 12, 2019 03:15AM
|
|
Re: Deadlines missed? Results Late? Not really.
|
3
|
Resverlogix Corp.
|
Jan 12, 2019 07:07PM
|
|
My own analysis
|
4
|
Resverlogix Corp.
|
Jan 15, 2019 07:29PM
|
|
Re: The waiting game.....Or a marathon
|
3
|
Resverlogix Corp.
|
Jan 18, 2019 01:13PM
|
